Botox Approved for Overactive Bladder
TUESDAY, Jan. 22 (HealthDay News) -- U.S. Food and Drug Administration approval of Botox (onabotulinumtoxinA) has been expanded to include adults with overactive bladder who don't respond to a class of drugs called anticholinergics.
Overactive bladder's typical symptoms including leakage, frequent urination and feeling the sudden and urgent need to urinate. Botox, when injected into the bladder, causes it to relax and increases its capacity, the FDA said in a news release.
In a clinical study, people treated with Botox after 12 weeks had urinary incontinence 1.6 to 1.9 times less per day than people treated with a placebo, the FDA said.
The most common adverse reactions recorded during the study included urinary tract infection, painful urination and incomplete bladder emptying (urinary retention). People who develop urinary retention may have to use a catheter until the situation resolves, the agency said.
Botox has been approved for several other uses, notably to treat facial wrinkles. The product is made by Allergan Inc., based in Irvine, Calif.
More information
Medline Plus has more about overactive bladder.
-- Scott Roberts
Copyright © 2013 HealthDay. All rights reserved.
Health News Today
Feed- Sugary Sodas, Fruit Punches May Raise Kidney Stone Risk: Study 05/15/2013
- Procedure for Incontinence in Women May Lose Effectiveness With Time 05/14/2013
- Vitamin D May Help Prevent Uterine Fibroids 04/17/2013
- New Procedure May Shrink Enlarged Prostate Without Surgery 04/15/2013
- High-Dose Statins Linked to Acute Kidney Damage 03/20/2013
- View More Kidneys and the Urinary System News
Popular Features
Take a Personalized Health Test
How well are you controlling your symptoms?
What's Causing Your Symptoms?
15 Ways To Get Better Medicine
People who are actively involved in their medical care stay healthier, recover quicker when they're ill, and live longer, healthier lives.